Echocardiography (ECG) Market Size, Share and Trends Report 2026 to 2035
Share With :
Echocardiography (ECG) Market Size is valued at USD 2.10 Bn in 2025 and is predicted to reach USD 4.18 Bn by the year 2035 at a 7.3% CAGR during the forecast period for 2026 to 2035.
Echocardiography (ECG) Market Size, Share & Trends Analysis Distribution by Test Type (Transthoracic Echocardiography, Stress Echocardiography, Transesophageal Echocardiography, and Others), Device Type (Handheld/Portable and Cart/Trolley-based), Technology (2D, 3D & 4D, and Doppler Imaging), End-user (Hospitals, Diagnostics Center, and Others), and Segment Forecasts, 2026 to 2035
-Market-info.webp "Echocardiography (ECG) Market info")
Echocardiography (ECG) Market Key Takeaways:
|
Echocardiography (ECG), sometimes referred to as cardiac ultrasound, is a technique used to identify cardiovascular disorders by producing images of the heart using sound waves. It aids in the identification of blood clots and the research of heart valves and chambers. A variety of tests are utilized for diagnostic procedures, such as transthoracic, transesophageal, and stress cardiac ultrasonography. Because it is non-invasive, transthoracic ultrasound is the most often used test. Echocardiography is a non-surgical medical procedure that diagnoses heart function by using high-frequency reflected sound. Holter monitors, stress ECGs, and resting ECGs are examples of ECG monitoring equipment that assist in detecting and providing information regarding aberrant heart activity. The increased use of echocardiography equipment as a result of growing cardiovascular disease prevalence, technology breakthroughs, and global healthcare infrastructure expansion is driving the market's expansion.
One of the main factors propelling the echocardiography (ECG) market is the rising incidence of cardiovascular illnesses. Over 17 million fatalities worldwide were attributed to cardiovascular illnesses in 2024, underscoring the critical need for early detection and surveillance. Non-invasive cardiac evaluations are made possible by echocardiography devices, which makes them essential for treating these disorders. Additionally, hospitals and diagnostic facilities around the world are adopting the practice more frequently as a result of government programs encouraging early detection. Furthermore, there is a tendency toward more complex training programs and ongoing medical education to help doctors employ these cutting-edge imaging modalities effectively. This higher degree of proficiency raises the quality of patient care and increases the accuracy of interpretation.
In addition, the use of 3D echocardiography technology is one of the key trends impacting the echocardiography (ECG) market. This cutting-edge imaging method improves diagnostic accuracy by providing a more thorough picture of heart structure and function. The echocardiography (ECG) market is also being driven by a rise in R&D activity for better technologies for electrocardiograph devices. Innovation in electrocardiograph design and the creation of new products both support the expansion of the market. Additionally, single-lead remote monitoring devices and portable ECG systems are expected to propel market expansion. However, some factors, like poor reimbursement regulations and growing market saturation, impede the echocardiography (ECG) market expansion. A further obstacle to the market's expansion is the shortage of qualified personnel to perform electrocardiographs.
• GE Healthcare
• Hitachi Medical Corporation
• Bay Labs
• Canon Medical Systems Corporation
• Esaote SpA
• Koninklijke Philips
• Siemens Healthineers
• Samsung Electronics
• Fujifilm Holdings Corporation
• ContextVision AB
• Digirad Corporation
• Bracco Imaging SpA
• TELEMED Medical Systems
The leading cause of death worldwide is cardiovascular illnesses (CVDs), which include heart failure, valvular heart disease, and coronary artery disease. For instance, according to the World Health Organization, cardiovascular diseases (CVDs) are the leading cause of death worldwide, accounting for 17.9 million deaths annually, or 32% of all fatalities worldwide. These diseases are becoming more common as a result of changing lifestyles, an aging population, obesity, and diabetes. Effective diagnostic tools that can facilitate improved early detection and therapy are becoming more and more necessary as heart-related disorders become more common. Since echocardiography is a non-invasive imaging method that is useful for objectively evaluating heart function, identifying anomalies, and deciding how best to treat heart ailments, its strong demand can be credited with the echocardiography (ECG) market's expansion.
The echocardiographic procedures are either not reimbursed or have limited reimbursement rules in several LMICs. This may also mean that all of the expenses related to echocardiography tests may not be covered by insurance or government health programs. This has resulted in increased out-of-pocket expenses for patients in numerous instances, which has reduced the demand for certain diagnostic services. Only a small percentage of fundamental healthcare services are covered by many governments, like Ghana's, and many advanced procedures, like echocardiography, are frequently not covered by the National Health Insurance Scheme (NHIS). Because of this, patients who require echocardiographic exams frequently have to pay for them out of pocket, which can cause significant financial challenges. Furthermore, the lack of funding and/or uncertainty around modern echocardiography equipment can discourage medical professionals from investing heavily in these technologies. In some areas, this financial obstacle limits the echocardiography (ECG) market expansion.
The Cart/Trolley-based category held the largest share in the Echocardiography (ECG) market in 2025 because of their widespread use in high-volume healthcare environments and their sophisticated imaging capabilities. These machines are crucial in tertiary hospitals where complex structural evaluations are common because they facilitate extensive diagnostic activities and exhibit exceptional image quality. In actuality, cart-based systems are used by more than 70% of major hospitals globally to control vital patient loads and guarantee accurate diagnosis. In order to further improve workflow efficiency and diagnosis accuracy, manufacturers are upgrading these systems with AI and cloud integration. Additionally, cart-based systems continue to be essential because of their multifunctionality and improved imaging capabilities, both of which are crucial in complex cardiovascular diagnoses.
In 2025, the 3D & 4D category dominated the Echocardiography (ECG) market. The devices for 3D and 4D echocardiography offer surgeons high-quality, real-time views of the heart, assisting them in selecting the best course of action. Heart diseases include cardiomyopathy, pericardial disease, and heart failure can be tracked using this technique in patients with CVDs. Additionally, it aids in the analysis of rhythmic abnormalities, coronary artery diseases, and more. The size, shape, thickness, and motion of the heart can be seen by the doctor due to 3D and 4D technologies. Because it also makes it possible to check for leaks or if the valves are operating correctly, the demand for 3D and 4D technologies is anticipated to increase during the projection period.
The Echocardiography (ECG) market was dominated by North America region in 2025 because of R&D expenditures, the abundance of advanced medical imaging tools, and the availability of a quality healthcare system. The area boasts top-notch diagnostic facilities and hospitals, and they have accelerated the use of innovative echocardiography equipment. This is the primary cause of the driving force, along with the growing number of persons experiencing heart-related issues. Additionally, GE HealthCare, Philips, Siemens Healthineers, Canon Medical Systems, and FUJIFILM Sonosite are the major participants in North America. To keep their leading positions, these businesses make use of advancements in portable echocardiography equipment, 3D/4D imaging, and AI integration. In hospitals in the United States and Canada, Lantheus and Bracco are the leading companies in the ultrasound contrast agent market.
-Market-region.webp "Echocardiography (ECG) Market region")
May 2025: The Netherlands-based Koninklijke Philips N.V., a leader in global health technology, unveiled its VeriSight Pro 3D Intracardiac Echocardiography (ICE) catheter in Europe. This development improves vision for minimally invasive operations such as left atrial appendage closure and transcatheter valve repair by bringing real-time 3D imaging within the heart. By enabling thorough heart imaging without the need for general anesthesia, the tiny ultrasound probe enhances patient comfort and shortens hospital stays.
| Report Attribute | Specifications |
| Market size value in 2025 | USD 2.10 Bn |
| Revenue forecast in 2035 | USD 4.18 Bn |
| Growth Rate CAGR | CAGR of 7.3% from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Bn and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2025 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | Test Type, Device Type, Technology, End-user, and By Region |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
| Competitive Landscape | GE Healthcare, Hitachi Medical Corporation, Bay Labs, Canon Medical Systems Corporation, Esaote SpA, Koninklijke Philips, Siemens Healthineers, Samsung Electronics, Fujifilm Holdings Corporation, ContextVision AB, Digirad Corporation, Bracco Imaging SpA, and TELEMED Medical Systems |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
• Transthoracic Echocardiography
• Stress Echocardiography
• Transesophageal Echocardiography
• Others
-Market-seg.webp "Echocardiography (ECG) Market seg")
• Handheld/Portable
• Cart/Trolley-based
• 2D
• 3D & 4D
• Doppler Imaging
• Hospitals
• Diagnostics Center
• Others
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.